MilliporeSigma and bluebird bio ink multi-year viral vector deal
Bluebird Bio has hired MilliporeSigma to supply lentiviral vectors for the development of gene therapies.
Bluebird Bio has hired MilliporeSigma to supply lentiviral vectors for the development of gene therapies.
Juno Therapeutics will use Thermo Fisher Scientific’s Cell Therapy Systems (CTS) technology to develop CAR T therapies for cancer treatments.